Your browser doesn't support javascript.
loading
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
Kwa, Maryann; Li, Xiaochun; Novik, Yelena; Oratz, Ruth; Jhaveri, Komal; Wu, Jennifer; Gu, Ping; Meyers, Marleen; Muggia, Franco; Speyer, James; Iwano, Alyssa; Bonakdar, Maryam; Kozhaya, Lina; Tavukcuoglu, Ece; Budan, Bahar; Raad, Roy; Goldberg, Judith D; Unutmaz, Derya; Adams, Sylvia.
Afiliação
  • Kwa M; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Li X; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Novik Y; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Oratz R; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Wu J; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Gu P; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Meyers M; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Muggia F; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Speyer J; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Iwano A; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Bonakdar M; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Kozhaya L; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
  • Tavukcuoglu E; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Budan B; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Raad R; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Goldberg JD; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Unutmaz D; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, 160 East 34th Street, New York, NY, 10016, USA.
  • Adams S; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Breast Cancer Res Treat ; 168(1): 57-67, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29124456
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos T Reguladores / Ciclofosfamida / Androstadienos Tipo de estudo: Etiology_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos T Reguladores / Ciclofosfamida / Androstadienos Tipo de estudo: Etiology_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos